Both in Pharmaceuticals
Lisata Therapeutics vs Dare Bioscience
Over the past year LSTA returned −41.9% and DARE returned −61.0%; their daily moves had a correlation of -0.02.
LSTA −41.9% DARE −61.0%Growth of $1, one year, split-adjusted
| Metric | LSTA | DARE |
|---|---|---|
| Price | $1.47 | $0.8150 |
| Market cap | $15.9M | $16.0M |
| Today | −2.00% | +8.67% |
| 1 month | −13.0% | +10.9% |
| 6 months | −70.7% | −55.5% |
| Year to date | −21.0% | −57.8% |
| 1 year | −40.5% | −61.0% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | −70.6% |
| Net margin | — | −1590.4% |
| P/E (TTM) | — | — |
| Price / sales | 158.8× | 11.7× |
| Net cash | $10.4M | $12.5M |
| Dividend yield | — | — |
| Volatility (60d) | 161.9% | 128.9% |
| Short % of float | 2.3% | 5.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).